Cargando…
Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignancies
Hepato-pancreatico-biliary (HPB) malignancies are difficult-to-treat and continue to to have a high mortality and significant therapeutic resistance to standard therapies. Immune oncology (IO) therapies have demonstrated efficacy in several solid malignancies when combined with chemotherapy, whereas...
Autores principales: | Wan, Shanshan, Zhao, Ende, Freeman, Daniel, Weissinger, Daniel, Krantz, Benjamin A., Werba, Gregor, Khanna, Lauren G., Siolas, Despina, Oberstein, Paul E., Chattopadhyay, Pratip K., Simeone, Diane M., Welling, Theodore H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927010/ https://www.ncbi.nlm.nih.gov/pubmed/36798126 http://dx.doi.org/10.3389/fimmu.2023.1067352 |
Ejemplares similares
-
Corrigendum: Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignancies
por: Wan, Shanshan, et al.
Publicado: (2023) -
Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment
por: Werba, Gregor, et al.
Publicado: (2023) -
Author Correction: Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment
por: Werba, Gregor, et al.
Publicado: (2023) -
POLQ inhibition elicits an immune response in homologous recombination–deficient pancreatic adenocarcinoma via cGAS/STING signaling
por: Oh, Grace, et al.
Publicado: (2023) -
The biological underpinnings of therapeutic resistance in pancreatic cancer
por: Beatty, Gregory L., et al.
Publicado: (2021)